Real-time enrollment status for this pulmonary hypertension due to lung diseases and hypoxia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:53 PM UTC
| NCT Number | NCT06388421 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension Due to Lung Diseases and Hypoxia |
| Phase | Clinical Trial |
| Target Enrollment | 900 participants |
| Active Locations | 70 sites in the US |
| Sponsor | United Therapeutics |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 12, 2026: Clinical trial NCT06388421 is currently recruiting participants. This clinical trial study for pulmonary hypertension due to lung diseases and hypoxia is actively seeking new participants at 70 locations across the United States. The study is sponsored by United Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06388421 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 70 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06388421 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.